Valuation (34%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -87.28 | 28.39 |
| PEG Ratio (TTM) | 12.22 | 9.19 |
| P/S Ratio (TTM) | 1.09 | 2.81 |
| P/B Ratio (TTM) | 2.84 | 8.94 |
| P/FCF Ratio (TTM) | 22.32 | 27.26 |
| Price to 5YR AVG Earnings Ratio | 115.33 | 37.45 |
| Price to 5YR AVG FCF Ratio | 113.17 | 41.44 |
Profitability (5%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -1.32% | 15.11% |
| ROE (TTM) | -3.21% | 31.67% |
| Net Profit Margin (TTM) | -1.25% | 8.82% |
| ROIC 5YR AVG | 5.83% | 31.32% |
Growth (57%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -221.93% | 8.15% | -43.72% |
| Revenue | 4.19% | 6.56% | 46.34% |
| Net Income | -222.25% | 29.25% | -30.92% |
| Cash Flow | 87.47% | 38.59% | 168.16% |
Health (37%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.50 | 2.82 |
| Quick Ratio (TTM) | 1.28 | 1.52 |
| D/E Ratio (TTM) | 0.95 | 0.59 |
| Interest Coverage (TTM) | 2.87 | 79.29 |
| Piotroski F-Score | 3 | 7 |
| Altman Z-Score | 2.49 | 11.89 |
| LTL to 5YR AVG FCF | 32.78 | 2.94 |
| Shares Outstanding Growth 5YR AVG | 40.92% | -0.63% |